Imperva (IMPV) Stock Rose While Eminence Capital LP Cut Position by $16.03 Million; Cornercap Investment Counsel Has Raised Charles Riv Labs Intl Com (CRL) Position by $359,100 as Stock Rose

February 13, 2018 - By Nellie Frank

Ricky Sandler decreased its stake in Imperva Inc (IMPV) by 11.37% based on its latest 2017Q3 regulatory filing with the SEC. Eminence Capital Lp sold 372,690 shares as the company’s stock rose 3.83% with the market. The hedge fund run by Ricky Sandler held 2.90M shares of the technology company at the end of 2017Q3, valued at $126.08 million, down from 3.28M at the end of the previous reported quarter. Eminence Capital Lp who had been investing in Imperva Inc for a number of months, seems to be less bullish one the $1.57 billion market cap company. The stock increased 0.22% or $0.1 during the last trading session, reaching $46. About 265,654 shares traded. Imperva, Inc. (NYSE:IMPV) has risen 38.26% since February 13, 2017 and is uptrending. It has outperformed by 21.56% the S&P500.

Cornercap Investment Counsel Inc increased its stake in Charles Riv Labs Intl Inc Com (CRL) by 24.12% based on its latest 2017Q3 regulatory filing with the SEC. Cornercap Investment Counsel Inc bought 3,325 shares as the company’s stock rose 1.24% with the market. The institutional investor held 17,110 shares of the health care company at the end of 2017Q3, valued at $1.85 million, up from 13,785 at the end of the previous reported quarter. Cornercap Investment Counsel Inc who had been investing in Charles Riv Labs Intl Inc Com for a number of months, seems to be bullish on the $5.04 billion market cap company. The stock increased 4.33% or $4.42 during the last trading session, reaching $106.41. About 559,733 shares traded or 53.32% up from the average. Charles River Laboratories International, Inc. (NYSE:CRL) has risen 7.06% since February 13, 2017 and is uptrending. It has underperformed by 9.64% the S&P500.

Cornercap Investment Counsel Inc, which manages about $912.27M and $711.52 million US Long portfolio, decreased its stake in Everest Re Group Ltd Com (NYSE:RE) by 12,715 shares to 22,378 shares, valued at $5.11 million in 2017Q3, according to the filing. It also reduced its holding in Bank New York Mellon Corp Com (NYSE:BK) by 34,255 shares in the quarter, leaving it with 30,235 shares, and cut its stake in Firstenergy Corp (NYSE:FE).

Among 16 analysts covering Charles River Laboratories (NYSE:CRL), 6 have Buy rating, 1 Sell and 9 Hold. Therefore 38% are positive. Charles River Laboratories had 41 analyst reports since August 3, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, November 16 by SunTrust. Bank of America maintained Charles River Laboratories International, Inc. (NYSE:CRL) rating on Friday, November 10. Bank of America has “Buy” rating and $115 target. The firm earned “Hold” rating on Monday, January 22 by SunTrust. The rating was reinitiated by Credit Suisse with “Neutral” on Friday, August 14. RBC Capital Markets maintained Charles River Laboratories International, Inc. (NYSE:CRL) on Thursday, November 2 with “Hold” rating. The firm has “Buy” rating by Jefferies given on Thursday, August 4. The firm has “Hold” rating by KeyBanc Capital Markets given on Monday, November 13. The firm has “Buy” rating given on Thursday, August 31 by Robert W. Baird. On Thursday, January 7 the stock rating was upgraded by Wells Fargo to “Outperform”. The stock of Charles River Laboratories International, Inc. (NYSE:CRL) has “Outperform” rating given on Friday, August 28 by William Blair.

Investors sentiment increased to 1.46 in 2017 Q3. Its up 0.09, from 1.37 in 2017Q2. It increased, as 18 investors sold CRL shares while 92 reduced holdings. 55 funds opened positions while 106 raised stakes. 44.95 million shares or 0.15% less from 45.02 million shares in 2017Q2 were reported. Commonwealth Of Pennsylvania School Empls Retrmt Sys holds 0.01% or 6,943 shares in its portfolio. Bokf Na reported 20,858 shares. First Quadrant Ltd Partnership Ca holds 0.01% or 6,010 shares in its portfolio. The California-based California Public Employees Retirement has invested 0.01% in Charles River Laboratories International, Inc. (NYSE:CRL). Utd Cap Fincl Advisers Ltd Limited Liability Company invested in 0.01% or 9,952 shares. The Michigan-based Ls Advsr Limited Liability has invested 0.02% in Charles River Laboratories International, Inc. (NYSE:CRL). 4,022 were accumulated by Raymond James Assoc. State Board Of Administration Of Florida Retirement System invested in 0.03% or 87,818 shares. Goldman Sachs Group Inc holds 0.03% or 1.02M shares in its portfolio. Bankshares Of Mellon reported 812,990 shares. Fdx Advisors reported 5,073 shares. The Florida-based Voloridge Investment Lc has invested 0.02% in Charles River Laboratories International, Inc. (NYSE:CRL). Alliancebernstein Limited Partnership has 0% invested in Charles River Laboratories International, Inc. (NYSE:CRL). Gotham Asset Management Ltd Liability Company stated it has 45,906 shares. Shaker Investments Limited Liability Oh invested in 0.6% or 8,040 shares.

Since August 14, 2017, it had 0 buys, and 4 selling transactions for $4.07 million activity. JOHST DAVID P had sold 24,759 shares worth $2.72 million. $171,228 worth of Charles River Laboratories International, Inc. (NYSE:CRL) was sold by Smith David Ross on Monday, August 14. The insider Molho Davide sold 6,165 shares worth $678,150. Barbo William D sold 4,000 shares worth $399,632.

Eminence Capital Lp, which manages about $10.55 billion and $6.18B US Long portfolio, upped its stake in Arris Intl Inc by 852,197 shares to 10.01 million shares, valued at $285.13M in 2017Q3, according to the filing. It also increased its holding in Wendys Co (NASDAQ:WEN) by 1.29 million shares in the quarter, for a total of 8.90M shares, and has risen its stake in Pandora Media Inc (NYSE:P).

Among 27 analysts covering Imperva (NYSE:IMPV), 16 have Buy rating, 2 Sell and 9 Hold. Therefore 59% are positive. Imperva had 78 analyst reports since August 5, 2015 according to SRatingsIntel. The company was maintained on Thursday, March 23 by DA Davidson. The stock has “Hold” rating by Stifel Nicolaus on Thursday, February 8. On Friday, October 30 the stock rating was maintained by RBC Capital Markets with “Outperform”. On Wednesday, September 2 the stock rating was upgraded by Buckingham Research to “Buy”. Deutsche Bank maintained the stock with “Buy” rating in Friday, August 7 report. On Friday, October 30 the stock rating was upgraded by Topeka Capital Markets to “Buy”. Needham maintained the shares of IMPV in report on Thursday, February 4 with “Buy” rating. Morgan Stanley downgraded the stock to “Underweight” rating in Thursday, April 21 report. The firm has “Sector Weight” rating by Pacific Crest given on Tuesday, August 30. The stock has “Buy” rating by Oppenheimer on Thursday, August 10.

Analysts await Imperva, Inc. (NASDAQ:IMPV) to report earnings on February, 14. They expect $-0.13 earnings per share, up 56.67% or $0.17 from last year’s $-0.3 per share. After $-0.01 actual earnings per share reported by Imperva, Inc. for the previous quarter, Wall Street now forecasts 1,200.00% negative EPS growth.

Investors sentiment decreased to 1.43 in 2017 Q3. Its down 0.17, from 1.6 in 2017Q2. It worsened, as 24 investors sold IMPV shares while 39 reduced holdings. 29 funds opened positions while 61 raised stakes. 29.31 million shares or 0.63% more from 29.13 million shares in 2017Q2 were reported. Robeco Institutional Asset Mngmt Bv reported 52,500 shares. 5,664 were accumulated by Us Bank De. Federated Investors Pa invested 0% of its portfolio in Imperva, Inc. (NASDAQ:IMPV). The New Jersey-based Jacobs Levy Equity Mgmt Incorporated has invested 0.1% in Imperva, Inc. (NASDAQ:IMPV). Indaba Mngmt LP invested 0.69% of its portfolio in Imperva, Inc. (NASDAQ:IMPV). Qs Invsts Ltd Liability Com owns 51,873 shares for 0.02% of their portfolio. Cambridge Trust owns 23,749 shares. Gsa Partners Llp has 0.04% invested in Imperva, Inc. (NASDAQ:IMPV) for 14,630 shares. Fund Mgmt invested in 0.03% or 87,951 shares. Nomura has 3,196 shares for 0% of their portfolio. New York-based Metropolitan Life Ins New York has invested 0.01% in Imperva, Inc. (NASDAQ:IMPV). Eagle Asset Management holds 0.32% of its portfolio in Imperva, Inc. (NASDAQ:IMPV) for 1.29M shares. State Street Corporation stated it has 633,951 shares or 0% of all its holdings. Tokio Marine Asset Management Com Limited stated it has 14,600 shares. Deutsche Bancorporation Ag holds 0.01% of its portfolio in Imperva, Inc. (NASDAQ:IMPV) for 439,872 shares.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>